Evidence map›Paper›PMID 24995785›Full record

ArticleJournal of neurosurgery2014

Minimally invasive convection-enhanced delivery of biologics into dorsal root ganglia: validation in the pig model and prospective modeling in humans. Technical note.

Josef Pleticha, Timothy P Maus, Jodie A Christner, Michael P Marsh, Kendall H Lee, W Michael Hooten, Andreas S Beutler

Open access · bronzeAbstract readValidation Study
In one paragraph

Article in Journal of neurosurgery, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Intravenous Administration of an AAV9 Vector Ubiquitously Expressing C1orf194 Gene Improved CMT-Like Neuropathy in C1orf194Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2023
    Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. AAV-Mediated Combination Gene Therapy for Neuropathic Pain: GAD65, GDNF, and IL-10.Molecular therapy. Methods & clinical development · 2020
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Gene therapy and peripheral nerve repair: a perspective.Frontiers in molecular neuroscience · 2015
    Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Josef PletichaDepartments of Anesthesiology.
Timothy P Maus
Jodie A Christner
Michael P Marsh
Kendall H Lee
W Michael Hooten
Andreas S Beutler
Mayo Clinic · USUniversity Radiology · US

Funding

EXTRAMURAL RES FACIL IMPROVEMENT PROG: POLYCYSTIC KIDNEY DISEASE, RENAL STUDIES,C06RR018898 · NCRR · MAYO CLINIC · PI BURNETT, JOHN C · 2004 to 2004
$2.3M
sc-rAAV8 via Lumbar Puncture as Spinal Analgesic Drug Delivery SystemsR01NS063022 · NINDS · MAYO CLINIC ROCHESTER · PI BEUTLER, ANDREAS S. · 2009 to 2013
$2.1M
NCRR NIH HHS C06 RR018898NINDS NIH HHS R01 NS063022
6 · The paper itself

Abstract

Dorsal root ganglia (DRG) are critical anatomical structures involved in nociception. Intraganglionic (IG) drug delivery is therefore an important route of administration for novel analgesic therapies. Although IG injection in large animal models is highly desirable for preclinical biodistribution and toxicology studies of new drugs, no method to deliver pharmaceutical agents into the DRG has been reported in any large species. The present study describes a minimally invasive technique of IG agent delivery in domestic swine, one of the most common large animal models. The technique utilizes CT guidance for DRG targeting and a custom-made injection assembly for convection enhanced delivery (CED) of therapeutic agents directly into DRG parenchyma. The DRG were initially visualized by CT myelography to determine the optimal access route to the DRG. The subsequent IG injection consisted of 3 steps. First, a commercially available guide needle was advanced to a position dorsolateral to the DRG, and the dural root sleeve was punctured, leaving the guide needle contiguous with, but not penetrating, the DRG. Second, the custom-made stepped stylet was inserted through the guide needle into the DRG parenchyma. Third, the stepped stylet was replaced by the custom-made stepped needle, which was used for the IG CED. Initial dye injections performed in pig cadavers confirmed the accuracy of DRG targeting under CT guidance. Intraganglionic administration of adeno-associated virus in vivo resulted in a unilateral transduction of the injected DRG, with 33.5% DRG neurons transduced. Transgene expression was also found in the dorsal root entry zones at the corresponding spinal levels. The results thereby confirm the efficacy of CED by the stepped needle and a selectivity of DRG targeting. Imaging-based modeling of the procedure in humans suggests that IG CED may be translatable to the clinical setting.

Indexed as

Ganglia, SpinalModels, AnimalAnimalsBiological ProductsConvectionHumansInjectionsSus scrofaTomography, X-Ray ComputedBiological ProductsAAV1 = AAV serotype 1AAV = adeno-associated virusCED = convection-enhanced deliverycomputed tomographyconvection-enhanced deliveryCTF = CT fluoroscopydorsal root gangliaDRG = dorsal root gangliaEGFP = enhanced green fluorescent proteingene therapyIG = intraganglionicintraganglionic injectionpainPBS = phosphate-buffered salineperipheral nerve

Identifiers

PMID24995785
PMCPMC5065916
OpenAlexW2004082638

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.